The precise calculation of the Anti-nuclear Antibody Testing Market Size is driven by a confluence of epidemiological data, diagnostic protocol adherence, and technological pricing. The foundational factor determining market size is the global prevalence and incidence of systemic autoimmune disorders. As conditions like SLE and Scleroderma are chronic and require continuous monitoring,...